164 related articles for article (PubMed ID: 22449370)
21. Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
Castor A; Nilsson L; Astrand-Grundström I; Buitenhuis M; Ramirez C; Anderson K; Strömbeck B; Garwicz S; Békássy AN; Schmiegelow K; Lausen B; Hokland P; Lehmann S; Juliusson G; Johansson B; Jacobsen SE
Nat Med; 2005 Jun; 11(6):630-7. PubMed ID: 15908956
[TBL] [Abstract][Full Text] [Related]
22. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
23. Clinically useful prognostic factors in acute myeloid leukemia.
Ferrara F; Palmieri S; Leoni F
Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
[TBL] [Abstract][Full Text] [Related]
24. HLA-DM expression is elevated in ETV6-AML1 translocation-positive pediatric acute lymphoblastic leukemia.
Jastaniah WA; Alessandri AJ; Reid GS; Schultz KR
Leuk Res; 2006 Apr; 30(4):487-9. PubMed ID: 16191436
[TBL] [Abstract][Full Text] [Related]
25. [Genetic and cytogenetic abnormalities in leukemia].
Nakamura F; Kurokawa M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():103-7. PubMed ID: 23133936
[No Abstract] [Full Text] [Related]
26. ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.
Zen PR; Capra ME; Silla LM; Loss JF; Fernandes MS; Jacques SM; Paskulin GA
Cancer Genet Cytogenet; 2009 Jan; 188(2):112-7. PubMed ID: 19100516
[TBL] [Abstract][Full Text] [Related]
27. Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: a case report.
Winkler J; Rech D; Kallert S; Rech J; Meidenbauer N; Roesler W; Mackensen A
Leuk Res; 2010 Oct; 34(10):e270-2. PubMed ID: 20627386
[No Abstract] [Full Text] [Related]
28. [Role of TEL gene alterations in childhood leukemias].
Eguchi M
Rinsho Ketsueki; 2011 Aug; 52(8):686-94. PubMed ID: 21897076
[No Abstract] [Full Text] [Related]
29. Update on the management of pediatric acute promyelocytic leukemia.
Ribeiro R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
[No Abstract] [Full Text] [Related]
30. Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.
Gao YJ; Zhu XH; Yang Y; Wu Y; Lu FJ; Zhai XW; Wang HS
Cancer Genet Cytogenet; 2007 Oct; 178(1):57-60. PubMed ID: 17889709
[TBL] [Abstract][Full Text] [Related]
31. [Evidence-based therapy for acute leukemia].
Matsuda M; Kanamaru A
Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):969-78. PubMed ID: 12866441
[No Abstract] [Full Text] [Related]
32. Abnormal hepatic function and splenomegaly on the newly diagnosed acute leukemia patients.
Sharma Poudel B; Karki L
JNMA J Nepal Med Assoc; 2007; 46(168):165-9. PubMed ID: 18340367
[TBL] [Abstract][Full Text] [Related]
33. Acute Myeloid Leukemia Genetics: Risk Stratification and Implications for Therapy.
Wang ML; Bailey NG
Arch Pathol Lab Med; 2015 Oct; 139(10):1215-23. PubMed ID: 26414465
[TBL] [Abstract][Full Text] [Related]
34. Treatment of adult acute leukemia.
McCauley DL
Clin Pharm; 1992 Sep; 11(9):767-96. PubMed ID: 1521402
[TBL] [Abstract][Full Text] [Related]
35. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
[TBL] [Abstract][Full Text] [Related]
36. B lymphoblastic leukemia with ETV6 amplification.
Chae H; Kim M; Lim J; Kim Y; Han K; Lee S
Cancer Genet Cytogenet; 2010 Dec; 203(2):284-7. PubMed ID: 21156245
[TBL] [Abstract][Full Text] [Related]
37. Genomics in acute myeloid leukemia: from identification to personalization.
Martin JM; Winer ES
R I Med J (2013); 2015 Nov; 98(11):27-30. PubMed ID: 26517252
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
Löwenberg B
N Engl J Med; 2008 May; 358(18):1960-2. PubMed ID: 18450608
[No Abstract] [Full Text] [Related]
39. Minimal residual disease in acute myeloid leukemia: already predicting a safe haven?
Schuurhuis GJ; Ossenkoppele G
Expert Rev Hematol; 2010 Feb; 3(1):1-5. PubMed ID: 21082928
[No Abstract] [Full Text] [Related]
40. Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.
Cairoli R; Beghini A; Turrini M; Bertani G; Nadali G; Rodeghiero F; Castagnola C; Lazzaroni F; Nichelatti M; Ferrara F; Pizzolo G; Pogliani E; Rossi G; Martinelli G; Morra E
Am J Hematol; 2013 Jul; 88(7):594-600. PubMed ID: 23619823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
